Last reviewed · How we verify
antioxidants
Antioxidants, developed by the University of Washington, are currently marketed but lack a specified primary indication or revenue data. The key composition patent is set to expire in 2028, which may provide a temporary barrier to generic competition. However, the absence of detailed clinical trial results and identified competitors poses a significant risk to assessing the drug's market sustainability and competitive landscape.
At a glance
| Generic name | antioxidants |
|---|---|
| Also known as | Bio-selenium, Pharma Nord (DK), Acetyl-L-carnitine (ALC), N-acetyl-L-cysteine (NAC), alpha-Lipoic acid (ALA), DEKAS Plus |
| Sponsor | University of Washington |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With Obesity (PHASE2)
- Anti-Inflammatory Effects of Pecan Nut Oil Supplementation in Adults With Overweight: A Randomized Controlled Parallel-Group Clinical Trial (NA)
- Epigallocatechin Gallate (EGCG) as a Flushing Agent During Full Pulpotomy in Mature Permanent Molars With Irreversible Pulpitis (NA)
- Vitamin E Pharmacokinetics and Biomarkers in Normal and Obese Women (PHASE1)
- Phenylalanine-free Diet for Patients With Secondary Hyperphenylalaninemia in ICU (NA)
- Novel Augmentation of DAOIB and Antioxidant for Early Dementia (PHASE2)
- Beetroot Beverage and Repeated Sprint Power Output During RAST (NA)
- Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19 (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- antioxidants CI brief — competitive landscape report
- antioxidants updates RSS · CI watch RSS
- University of Washington portfolio CI